Entos Pharmaceuticals Inc. is a clinical-stage genetic medicines company. A new reality in genetic medicine lies ahead, one that will be ushered in with the advent of safe, effective, and redosable nucleic acid delivery technologies. At Entos, we develop next generation genetic medicines using our proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system. Fusogenix PLVs are formulated with FAST proteins to enable the delivery of nucleic acid into target cells through direct fusion.
View Top Employees from Entos Pharmaceuticals| Website | http://www.entospharma.com |
| Revenue | $8.1 million |
| Employees | 50 (45 on RocketReach) |
| Founded | 2016 |
| Address | 10230 Jasper Avenue, Unit 4550, Edmonton, Alberta T5J 4P6, CA |
| Phone | (780) 862-7445 |
| Technologies |
JavaScript,
HTML,
Twitter
+12 more
(view full list)
|
| Industry | Biotechnology, Manufacturing General, Manufacturing, Science and Engineering |
| Competitors | Apellis Pharmaceuticals, Carticept Medical, Inc., Heron Therapeutics, Inc., Impel NeuroPharma, Oramed Pharmaceuticals Inc. |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 541711 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Entos Pharmaceuticals employee's phone or email?
Entos Pharmaceuticals Questions
The Entos Pharmaceuticals annual revenue was $8.1 million in 2024.
Jason Ding is the Chief Business Officer of Entos Pharmaceuticals.
45 people are employed at Entos Pharmaceuticals.
Entos Pharmaceuticals is based in Edmonton, Alberta.
The NAICS codes for Entos Pharmaceuticals are [541711, 32, 541, 325, 54171, 54, 5417].
The SIC codes for Entos Pharmaceuticals are [28, 283, 2834].
Top Entos Pharmaceuticals Employees
-
5+5+
-
21
-
1
-
3
-
5+3
-
35+
-
31
-
1
Related Companies
